FDA proposes rule to notify women with dense breasts about increased cancer risk and imprecise mammograms
The FDA is proposing a rule for breast cancer screenings that would require doctors to give women more information about the risks associated with dense breasts. Read the full article here.
Caduceus Chief Medical Officer, Gregg DeNicola MD, shares his take for our patients.
“Informing women that their amount of breast density may affect results of the mammogram and their risks be outlined just makes common sense; it’s hard to imagine any body opposing this recommendation. Yes; it is more time necessary to advise patients as the physician, but it is essential women are educated on the details of their mammogram. In California, such a requirement already exists and is enforced so it will have little impact for our patients, but to set this as a national standard is just smart medicine.”